67) Research on architectural competence in pharmaceutical firms suggests that
A) not only do some firms possess this competence, but that other firms do not; firms without
this competence have, on average, been able develop it with minimal investment.
B) very few firms possess this competence, but firms without this competence, on average, are
able to develop it.
C) not only do some firms possess this competence, but also that other firms do not and firms
without this competence have, on average, been unable to develop it.
D) virtually every firm possesses this competence to some extent.
68) Which of the following bases of product differentiation is generally viewed as the most
difficult to duplicate?
A) Product features
B) Reputation
C) Linkages with other firms
D) Location
69) The U-form structure used to implement a product-differentiation strategy
A) rarely uses temporary cross-divisional and cross-functional teams to manage the development
and implementation of new, innovative, and highly differentiated products.
B) has simple reporting relationships.
C) often uses temporary cross-divisional and cross-functional teams to manage the development
and implementation of new, innovative, and highly differentiated products.
D) has a small corporate staff.
70) A ________ structure exists when individuals in a firm have two or more bosses
simultaneously.
A) U-form
B) multidivisional
C) cross-divisional
D) matrix